Pennsylvania Trust Co decreased its stake in UnitedHealth Group Inc (NYSE:UNH) by 7.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,258 shares of the healthcare conglomerate’s stock after selling 1,969 shares during the period. Pennsylvania Trust Co’s holdings in UnitedHealth Group were worth $7,719,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Selective Wealth Management Inc. acquired a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $27,000. North Star Investment Management Corp. bought a new stake in UnitedHealth Group in the 3rd quarter valued at $30,000. Delta Asset Management LLC TN grew its holdings in UnitedHealth Group by 111.0% in the 3rd quarter. Delta Asset Management LLC TN now owns 154 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 81 shares in the last quarter. Fusion Family Wealth LLC grew its holdings in UnitedHealth Group by 329.7% in the 3rd quarter. Fusion Family Wealth LLC now owns 159 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 122 shares in the last quarter. Finally, Massey Quick Simon & CO. LLC increased its position in UnitedHealth Group by 212.5% during the 3rd quarter. Massey Quick Simon & CO. LLC now owns 175 shares of the healthcare conglomerate’s stock worth $38,000 after buying an additional 119 shares during the period. 85.44% of the stock is owned by hedge funds and other institutional investors.
A number of brokerages have recently issued reports on UNH. Morgan Stanley reissued a “buy” rating and issued a $312.00 target price (up previously from $294.00) on shares of UnitedHealth Group in a research report on Friday, November 22nd. ValuEngine upgraded shares of UnitedHealth Group from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. Citigroup increased their price target on UnitedHealth Group from $286.00 to $346.00 and gave the stock a “buy” rating in a research report on Thursday. Oppenheimer lifted their price objective on UnitedHealth Group from $312.00 to $343.00 and gave the company an “outperform” rating in a report on Thursday. Finally, UBS Group increased their target price on UnitedHealth Group from $279.00 to $304.00 and gave the stock a “neutral” rating in a report on Thursday. Five research analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $313.50.
Shares of UNH stock traded up $2.24 during trading hours on Thursday, hitting $298.66. 368,118 shares of the company’s stock were exchanged, compared to its average volume of 2,752,997. UnitedHealth Group Inc has a 12-month low of $208.07 and a 12-month high of $300.00. The company has a market capitalization of $273.08 billion, a PE ratio of 23.19, a PEG ratio of 1.37 and a beta of 0.65. The business’s 50 day simple moving average is $288.46 and its 200-day simple moving average is $255.03. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Wednesday, January 15th. The healthcare conglomerate reported $3.90 EPS for the quarter, topping analysts’ consensus estimates of $3.77 by $0.13. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The company had revenue of $60.90 billion for the quarter, compared to analysts’ expectations of $61.17 billion. During the same quarter last year, the company earned $3.28 EPS. The firm’s revenue was up 4.3% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Inc will post 14.98 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $1.08 per share. The ex-dividend date was Friday, December 6th. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.45%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 33.54%.
In other UnitedHealth Group news, EVP D Ellen Wilson sold 7,400 shares of the business’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $272.77, for a total value of $2,018,498.00. Also, CAO Thomas E. Roos sold 1,177 shares of the company’s stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $255.04, for a total transaction of $300,182.08. Following the transaction, the chief accounting officer now directly owns 21,687 shares of the company’s stock, valued at $5,531,052.48. The disclosure for this sale can be found here. 0.87% of the stock is currently owned by insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: Accumulation/Distribution
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.